Protective Effects of a Mixed Medicinal Herb Extract (NUC1) on Collagenase-Induced Osteoarthritis in Rabbits
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
NUC1 (Nutraceutical compound 1) is an ethanol extract composed of a formulation based on medicinal herbs traditionally used for the treatment of arthritis in Korea and China. This study investigated the therapeutic effects of NUC1 on osteoarthritis (OA). The protective effect of NUC1 on OA was tested in a rabbit model of collagenase-induced arthritis (CIA) for 4 weeks. Results were compared among four groups (n = 9 per group): the normal group (untreated), the CIA group (vehicle control), the NUC1 group (CIA rabbits treated with 200 mg/kg NUC1), and the JOINS group (positive control, CIA rabbits treated with 200 mg/kg JOINS tablet). NUC1 significantly inhibited NO production (p < 0.05 at 125 μg/ml, p < 0.01 at 250 μg/ml, and p < 0.001 at 500 μg/ml) and iNOS expression in macrophages, in a concentration-dependent manner. NUC1 also inhibited the release and protein expression of MMP-1, 3, and 13, in TNF-α-induced chondrosarcoma cells in a concentration-dependent manner. In vivo, the MMP-1 and MMP-3 levels in synovial fluids were significantly (p < 0.05) lower in NUC1 group (77.50 ± 20.56 and 22.50 ± 7.39 pg/ml, respectively) than in the CIA group (148.33 ± 68.58 and 77.50 ± 20.46 pg/ml, respectively). Also, in histopathological, NUC1 ameliorated articular cartilage damage in OA by increasing the abundance of chondrocytes and proteoglycan in the articular cartilage. Thus, NUC1 showed promise as a potential therapeutic agent, and it can be generalized to a broader study population in different OA animal models.
Abstract
NUC1 (Nutraceutical compound 1) is an ethanol extract composed of a formulation based on medicinal herbs traditionally used for the treatment of arthritis in Korea and China. This study investigated the therapeutic effects of NUC1 on osteoarthritis (OA). The protective effect of NUC1 on OA was tested in a rabbit model of collagenase-induced arthritis (CIA) for 4 weeks. Results were compared among four groups (n = 9 per group): the normal group (untreated), the CIA group (vehicle control), the NUC1 group (CIA rabbits treated with 200 mg/kg NUC1), and the JOINS group (positive control, CIA rabbits treated with 200 mg/kg JOINS tablet). NUC1 significantly inhibited NO production (p < 0.05 at 125 μg/ml, p < 0.01 at 250 μg/ml, and p < 0.001 at 500 μg/ml) and iNOS expression in macrophages, in a concentration-dependent manner. NUC1 also inhibited the release and protein expression of MMP-1, 3, and 13, in TNF-α-induced chondrosarcoma cells in a concentration-dependent manner. In vivo, the MMP-1 and MMP-3 levels in synovial fluids were significantly (p < 0.05) lower in NUC1 group (77.50 ± 20.56 and 22.50 ± 7.39 pg/ml, respectively) than in the CIA group (148.33 ± 68.58 and 77.50 ± 20.46 pg/ml, respectively). Also, in histopathological, NUC1 ameliorated articular cartilage damage in OA by increasing the abundance of chondrocytes and proteoglycan in the articular cartilage. Thus, NUC1 showed promise as a potential therapeutic agent, and it can be generalized to a broader study population in different OA animal models.
참고문헌 (43)
- Orhan C, "Undenatured type II collagen ameliorates inflammatory responses and articular cartilage damage in the rat model of osteoarthritis", Front. Vet. Sci, 8, pp.617789~ (2021)
- Sifre V, "Improved joint health following oral administration of glycosaminoglycans with native type ii collagen in a rabbit model of osteoarthritis", Animals (Basel), 12 (2022)[DOI]
- Goldring MB, "Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis", Ann. NY Acda. Sci, 1192, pp.230~237 (2010)
- Kraus VB, "Pathogenesis and treatment of osteoarthritis", Med. Clin. North Am, 81, pp.85~112 (1997)
- Dean DD, "Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritis cartilage", J. Clin. Investig, 84, pp.678~685 (1989)
- Bijlsma JW, "Osteoarthritis: an update with relevance for clinical practice", Lancet, 377, pp.2115~2126 (2011)
- Hawkey C, "The rofecoxib osteoarthritis endoscopy multinational study group. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo controlled trial", Arthritis Rheum, 43, pp.370~377 (2000)
- 심우형, "五加皮 樹皮와 根皮의 MIA 유도 골관절염 흰쥐에 미치는 영향 비교", 대한본초학회지, 33(5), pp.53~66 (2018), 대한본초학회[DOI]
- 이부균, "Collagen Ⅱ-induced Arthritis 생쥐에 대한 杜仲․續斷 배합약물의 관절염 억제 효과", 대한본초학회지, 25(1), pp.55~63 (2010), 대한본초학회
- Lee JS, "Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response", J. Ethnopharmacol, 117, pp.34~40 (2008)
- 조형권, "해동피를 포함한 생약복합제제 HP-04의 퇴행성 골관절염에 대한 항염효과", 생약학회지, 51(2), pp.122~130 (2020), 한국생약학회[DOI]
- 이성규, "단일 생약재 및 생약복합제 에탄올추출물의 항산화 및 항염증 활성", 한국식품과학회지, 43(2), pp.200~205 (2011), 한국식품과학회
- Lee S, (1978), ChungKuK ChungEuiHak
- Lee SG, "Anti-inflammatory and anti-osteoarthritis effects of fermented Achyranthes japonica Nakai", J. Ethnopharmacol, 142, pp.634~641 (2012)
- Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J. Immunol. Methods, 65, pp.55~63 (1983)
- Green LC, "Analysis of nitrate, nitrite and (15N) nitrate in biological fluids", Anal. Biochem, 126, pp.131~138 (1982)
- Gogly B, "Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase", Anal. Biochem, 255, pp.211~216 (1998)
- Kikuchi T, "Intra-articular injection of collagenase experimental osteoarthritis in mature rabbits", Osteoarthr. Cartil, 6, pp.177~186 (1998)
- Pritzker KP, "Osteoarthritis cartilage histopathology: grading and staging Osteoarthr", Cartil, 14, pp.13~29 (2006)
- El-Baz FK, "Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats", Toxicol. Rep, 7, pp.36~45 (2020)
- Troeberg L, "Proteases involved in cartilage matrix degradation in osteoarthritis", Biochim. Biophys. Acta, 1824, pp.133~145 (2011)
- Felson DT, "Developments in the clinical understanding of osteoarthritis", Arthritis Res. Ther, 11, pp.203~ (2009)
- Martel-Pelletier J, "Pathophysiology of osteoarthritis", Osteoarthr. Cartil, 6, pp.374~376 (1998)
- Benito MJ, "Synovial tissue inflammation in early and late osteoarthritis", Ann. Rheum. Dis, 64, pp.1263~1267 (2005)
- Deng JS, "Antioxidant, analgesic, and anti-inflammatory activities of the ethanol extracts of Taxillus liquidambaricola", J. Ethnopharmacol, 137, pp.1161~1171 (2011)
- Tchetcerikov I, "MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis", Ann. Rheum. Dis, 64, pp.694~698 (2005)
- Brennan FM, "Evidence that cytokines play a role in rheumatoid arthritis", J. Clin. Investig, 118, pp.3537~3545 (2008)
- Jeffery J, "Matrix Metalloproteinases", pp.15~38 (1998), Academic Press
- Visse R, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry", Circ. Res, 92, pp.827~839 (2003)
- Birkedal-Hansen H, "Matrix metalloproteinases: a review", Crit. Rev. Oral Biol. Med, 4, pp.197~250 (1993)
- Goldring MB, "The role of the chondrocyte in osteoarthritis", Arthritis Rheum, 43, pp.1916~1926 (2000)
- Billinghurst RC, "Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage", J. Clin. Investig, 99, pp.1534~1545 (1997)
- Neuhold LA, "Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice", J. Clin. Investig, 107, pp.35~44 (2001)
- van den Berg WB, "Pathophysiology of osteoarthritis", Joint Bone Spine, 67, pp.555~556 (2000)
- Loeser RF, "Osteoarthritis: a disease of the joint as an organ", Arthritis Rheum, 64, pp.1697~1707 (2012)
- Cunnane G, "Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis", Arthritis Rheum, 44, pp.2263~2274 (2001)
- Gosset M, "Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1", J. Immunol, 185, pp.6244~6252 (2010)
- Li Y, "The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of apigenin on collagen-induced arthritis", Int. Immunopharmacol, 73, pp.362~369 (2019)
- Hussain T, "Health-promoting properties of Eucommia ulmoides: a review", Evid. Based Complement. Alternat. Med, 2016, pp.5202908~ (2016)
- Choi JW, "Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals", J. Ethnopharmacol, 79, pp.199~204 (2002)
- Fikry EM, "Caffeic acid and ellagic acid ameliorate adjuvant-induced arthritis in rats via targeting inflammatory signals, chitinase-3-like protein-1 and angiogenesis", Biomed. Pharmacother, 110, pp.878~886 (2019)
- Du K, "Ferulic acid suppresses interleukin‐1β‐induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1", AMPK, Immun. Inflamm. Dis, pp.2021, 9[DOI]
- Wang H, "Quercetin prevents osteoarthritis progression possibly via regulation of local and systemic inflammatory cascades", J. Cell. Mol. Med, 27, pp.471~592 (2023)